$NEXT
NextDecade Corp. Stock $next

$next Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000162828024010236 Filed on March 11, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023 Q3
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$35.52M	$29.17M	$34.71M
YoY Change	33.51%	44.61%	132.72%
% of Gross Profit
Research & Development	$2.509M	$2.926M	$1.080M
YoY Change	440.73%	1166.67%	-4.68%
% of Gross Profit
Depreciation & Amortization	$84.00K	$51.00K	$42.00K
YoY Change	121.05%	54.55%	2.44%
% of Gross Profit
Operating Expenses	$38.12M	$32.15M	$35.84M
YoY Change	40.6%	57.31%	122.73%
Operating Profit	-$38.12M		-$35.84M
YoY Change	40.6%		122.73%
Interest Expense	$25.48M	-$216.7M	$32.54M
YoY Change
% of Operating Profit
Other Income/Expense, Net	$224.9M	$2.526M	$217.7M
YoY Change	-94991.14%	67.28%	-8138.37%
Pretax Income	$186.8M	-$255.8M	$181.8M
YoY Change	-782.98%	1251.9%	-1067.39%
Income Tax	$0.00		$0.00
% Of Pretax Income	0.0%		0.0%
Net Earnings	$186.8M	-$129.3M	$181.8M
YoY Change	-782.98%	408.32%	-1067.41%
Net Earnings / Revenue
Basic Earnings Per Share	$0.11		$0.48
Diluted Earnings Per Share	$0.11	-$0.50	$0.48
COMMON SHARES
Basic Shares Outstanding	256.7M shares	256.6M	241.4M
Diluted Shares Outstanding	266.9M shares		226.3M

Balance Sheet

Concept	2024 Q1	2023 Q4	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$45.75M	$38.24M	$50.80M
YoY Change	-10.54%	-39.1%	-53.49%
Cash & Equivalents	$45.80M	$38.20M	$50.80M
Short-Term Investments
Other Short-Term Assets	$3.193M	$2.089M	$126.0K
YoY Change	582.26%	1852.34%	-76.97%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$283.9M	$314.5M	$469.2M
YoY Change	438.63%	391.92%	324.47%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.158B	$2.438B	$1.714B
YoY Change	1195.05%	1014.92%	837.43%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$17.05M	$11.02M	$11.02M
YoY Change	-43.36%	-61.16%	-58.1%
Total Long-Term Assets	$3.892B	$3.009B	$2.429B
YoY Change	1314.26%	1111.02%	1055.77%
TOTAL ASSETS
Total Short-Term Assets	$283.9M	$314.5M	$469.2M
Total Long-Term Assets	$3.892B	$3.009B	$2.429B
Total Assets	$4.176B	$3.324B	$2.898B
YoY Change	1173.5%	963.85%	803.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$175.4M	$243.1M	$326.8M
YoY Change	9359.76%	22328.87%	6587.5%
Accrued Expenses	$322.0M	$299.3M	$362.8M
YoY Change	987.57%	1132.5%	2898.59%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due			$0.00
YoY Change
Total Short-Term Liabilities	$505.7M	$552.4M	$550.7M
YoY Change	1349.19%	2078.1%	3134.46%
LONG-TERM LIABILITIES
Long-Term Debt	$2.394B	$1.816B	$1.382B
YoY Change
Other Long-Term Liabilities	$5.297M	$0.00	$0.00
YoY Change	-76.97%	-100.0%	-100.0%
Total Long-Term Liabilities	$2.394B	$1.816B	$1.382B
YoY Change	10307.52%	7796.96%	5907.93%
TOTAL LIABILITIES
Total Short-Term Liabilities	$505.7M	$552.4M	$550.7M
Total Long-Term Liabilities	$2.394B	$1.816B	$1.382B
Total Liabilities	$3.045B	$2.583B	$2.081B
YoY Change	4815.8%	4545.01%	4198.96%
SHAREHOLDERS EQUITY
Retained Earnings	-$363.4M	-$391.8M	-$262.5M
YoY Change	41.14%	70.23%	24.28%
Common Stock			$26.00K
YoY Change			85.71%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$14.31M	$14.21M	$14.19M
YoY Change	208.76%	209.88%	243.93%
Treasury Stock Shares
Shareholders Equity	$520.1M	$287.9M	$477.0M
YoY Change
Total Liabilities & Shareholders Equity	$4.176B	$3.324B	$2.898B
YoY Change	1173.5%	963.85%	803.73%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023 Q3
OPERATING ACTIVITIES
Net Income	$186.8M	-$129.3M	$181.8M
YoY Change	-782.98%	408.32%	-1067.41%
Depreciation, Depletion And Amortization	$84.00K	$51.00K	$42.00K
YoY Change	121.05%	54.55%	2.44%
Cash From Operating Activities	-$28.83M	-$20.99M	-$11.43M
YoY Change	24.33%	73.28%	9.0%
INVESTING ACTIVITIES
Capital Expenditures	$790.3M	$742.4M	$954.0M
YoY Change	3571.18%	2385.14%	-19949.56%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$796.4M	-$742.4M	-$954.0M
YoY Change	3302.83%	2385.14%	19749.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$782.1M	612.0M	1.371B
YoY Change	2138.44%	-13861.5%	1532.14%
NET CHANGE
Cash From Operating Activities	-$28.83M	-20.99M	-11.43M
Cash From Investing Activities	-$796.4M	-742.4M	-954.0M
Cash From Financing Activities	$782.1M	612.0M	1.371B
Net Change In Cash	-$43.08M	-151.4M	405.8M
YoY Change	269.85%	226.01%	490.54%
FREE CASH FLOW
Cash From Operating Activities	-$28.83M	-$20.99M	-$11.43M
Capital Expenditures	$790.3M	$742.4M	$954.0M
Free Cash Flow	-$819.2M	-$763.4M	-$965.4M
YoY Change	1732.03%	1718.07%	16896.48%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001612720
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-36842
CY2023	dei	Entity Registrant Name EntityRegistrantName	NEXTDECADE CORPORATION
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-5723951
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	1000 Louisiana Street, Suite 3900
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Houston
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	77002
CY2023	dei	City Area Code CityAreaCode	713
CY2023	dei	Local Phone Number LocalPhoneNumber	574-1880
CY2023	dei	Security12b Title Security12bTitle	Common stock $0.0001 par value
CY2023	dei	Trading Symbol TradingSymbol	NEXT
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	376400000	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	256708470	shares
CY2023	dei	Auditor Firm AuditorFirmId	248
CY2023	dei	Auditor Name AuditorName	GRANT THORNTON LLP
CY2023	dei	Auditor Location AuditorLocation	Houston, Texas
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	38241000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	62789000	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	256237000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	0	usd
CY2023Q4	us-gaap	Derivative Assets Current DerivativeAssetsCurrent	17958000	usd
CY2022Q4	us-gaap	Derivative Assets Current DerivativeAssetsCurrent	0	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2089000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1149000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	314525000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	63938000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2437733000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	218646000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	170827000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1474000	usd
CY2023Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	389695000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	0	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	11021000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	28372000	usd
CY2023Q4	us-gaap	Assets Assets	3323801000	usd
CY2022Q4	us-gaap	Assets Assets	312430000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	243129000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1084000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	299264000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	54371000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	23184000	usd
CY2023Q4	next	Common Stock Warrant Liabilities Current CommonStockWarrantLiabilitiesCurrent	6851000	usd
CY2022Q4	next	Common Stock Warrant Liabilities Current CommonStockWarrantLiabilitiesCurrent	0	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3143000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1093000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	552387000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	25361000	usd
CY2023Q4	next	Common Stock Warrant Liabilities Noncurrent CommonStockWarrantLiabilitiesNoncurrent	1818000	usd
CY2022Q4	next	Common Stock Warrant Liabilities Noncurrent CommonStockWarrantLiabilitiesNoncurrent	6790000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	145962000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	465000	usd
CY2023Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	66899000	usd
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	0	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1816301000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	0	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	23000000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	2583367000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	55616000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	202443000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	480000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	480000000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	256500000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	256500000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	143500000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	143500000	shares
CY2023Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	26000	usd
CY2022Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	14000	usd
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	2200000	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	1000000	shares
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	14214000	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	4587000	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	693883000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	289084000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-391772000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-230140000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	287923000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	54371000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	452511000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	0	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	740434000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3323801000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	312430000	usd
CY2023	us-gaap	Revenues Revenues	0	usd
CY2022	us-gaap	Revenues Revenues	0	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	111468000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	49093000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4891000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4101000	usd
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	6141000	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	1119000	usd
CY2023	us-gaap	Depreciation Depreciation	168000	usd
CY2022	us-gaap	Depreciation Depreciation	162000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	54475000	usd
CY2023	next	Gain Loss On Common Stock Warrant Liabilities GainLossOnCommonStockWarrantLiabilities	-1879000	usd
CY2022	next	Gain Loss On Common Stock Warrant Liabilities GainLossOnCommonStockWarrantLiabilities	-5747000	usd
CY2023	us-gaap	Interest Expense InterestExpense	50285000	usd
CY2022	us-gaap	Interest Expense InterestExpense	0	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-9531000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	7526000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	151000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-98972000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5596000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-221640000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-60071000	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-59379000	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	usd
CY2023	us-gaap	Dividends Preferred Stock DividendsPreferredStock	20484000	usd
CY2022	us-gaap	Dividends Preferred Stock DividendsPreferredStock	24282000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-182745000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-84353000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.94
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.94
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.65
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.65
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	194595000	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	194595000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	130136000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	130136000	shares
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	54371000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	19892000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	287923000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	54371000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	740434000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	54371000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-221640000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-60071000	usd
CY2023	us-gaap	Depreciation Depreciation	168000	usd
CY2022	us-gaap	Depreciation Depreciation	162000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	26553000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	7472000	usd
CY2023	next	Gain Loss On Common Stock Warrant Liabilities GainLossOnCommonStockWarrantLiabilities	-1879000	usd
CY2022	next	Gain Loss On Common Stock Warrant Liabilities GainLossOnCommonStockWarrantLiabilities	-5747000	usd
CY2023	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-44803000	usd
CY2022	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	0	usd
CY2023	next	Net Cash Provided By Settlement Of Derivative Instruments NetCashProvidedBySettlementOfDerivativeInstruments	4138000	usd
CY2022	next	Net Cash Provided By Settlement Of Derivative Instruments NetCashProvidedBySettlementOfDerivativeInstruments	0	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	2980000	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	756000	usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	5712000	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	41390000	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-9531000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2023	us-gaap	Paid In Kind Interest PaidInKindInterest	26432000	usd
CY2022	us-gaap	Paid In Kind Interest PaidInKindInterest	0	usd
CY2023	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	0	usd
CY2022	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	354000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	940000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	314000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4057000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	684000	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-179000	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-678000	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-7080000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	5812000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-73620000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-40076000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1737636000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	33753000	usd
CY2023	next	Payments To Acquire Other Noncurrent Assets PaymentsToAcquireOtherNoncurrentAssets	15164000	usd
CY2022	next	Payments To Acquire Other Noncurrent Assets PaymentsToAcquireOtherNoncurrentAssets	7135000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1752800000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-40888000	usd
CY2023	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	2083000000	usd
CY2022	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	usd
CY2023	next	Proceeds From Sale Of Subsidiary ProceedsFromSaleOfSubsidiary	457659000	usd
CY2022	next	Proceeds From Sale Of Subsidiary ProceedsFromSaleOfSubsidiary	0	usd
CY2023	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	10500000	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	254400000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	115000000	usd
CY2023	us-gaap	Repayments Of Debt RepaymentsOfDebt	233000000	usd
CY2022	us-gaap	Repayments Of Debt RepaymentsOfDebt	0	usd
CY2023	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	494270000	usd
CY2022	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	3952000	usd
CY2023	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	53000	usd
CY2022	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	75000	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	9627000	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	3272000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2058109000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	118201000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	231689000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	37237000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	62789000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	25552000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	294478000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	62789000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	38241000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	256237000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	294478000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	38200000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of Consolidated Financial Statements in conformity with GAAP requires management to make certain estimates and assumptions that affect the amounts reported in the Consolidated Financial Statements and the accompanying notes. Management evaluates its estimates and related assumptions regularly, including those related to the value of property, plant and equipment, income taxes including valuation allowances for net deferred tax assets, share-based compensation and fair value measurements. Changes in facts and circumstances or additional information may result in revised estimates, and actual results may differ from these estimates.</span></div>
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:6pt;padding-right:7.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentrations of Credit Risk</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject us to a concentration of credit risk consist principally of cash and cash equivalents. We maintain cash and cash equivalent balances with a single financial institution, which may at times be in excess of federally insured levels. We have not incurred losses related to these cash and cash equivalent balances to date.</span></div>
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1174000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2438907000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	219652000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1006000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2437733000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	218646000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P30Y
CY2023Q4	next	Lessee Operating Lease Number Of Consecutive Renewal Term LesseeOperatingLeaseNumberOfConsecutiveRenewalTerm	2	renewal_period
CY2023Q4	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P10Y
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	6100000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	1100000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	8029000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	7615000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	9522000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	9565000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	9609000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	199241000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	243581000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	94476000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	149105000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P27Y10M24D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.040
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	3122000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	678000	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	147727000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1640000	usd
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	23184000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	781000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	4488000	usd
CY2023Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	299264000	usd
CY2023Q4	next	Prepaid Contributions In Aid Of Contraction Noncurrent PrepaidContributionsInAidOfContractionNoncurrent	7534000	usd
CY2022Q4	next	Prepaid Contributions In Aid Of Contraction Noncurrent PrepaidContributionsInAidOfContractionNoncurrent	0	usd
CY2023Q4	next	Permitting Costs Noncurrent PermittingCostsNoncurrent	0	usd
CY2022Q4	next	Permitting Costs Noncurrent PermittingCostsNoncurrent	8575000	usd
CY2023Q4	next	Leases Initial Direct Costs Noncurrent LeasesInitialDirectCostsNoncurrent	0	usd
CY2022Q4	next	Leases Initial Direct Costs Noncurrent LeasesInitialDirectCostsNoncurrent	19612000	usd
CY2023Q4	next	Deposits And Other Assets Noncurrent DepositsAndOtherAssetsNoncurrent	3487000	usd
CY2022Q4	next	Deposits And Other Assets Noncurrent DepositsAndOtherAssetsNoncurrent	185000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	11021000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	28372000	usd
CY2023Q4	next	Business Acquisition Deferred Transaction Costs Current BusinessAcquisitionDeferredTransactionCostsCurrent	268821000	usd
CY2022Q4	next	Business Acquisition Deferred Transaction Costs Current BusinessAcquisitionDeferredTransactionCostsCurrent	12046000	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	20392000	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	0	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	9270000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	6650000	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1850000000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	33699000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	1816301000	usd
CY2023Q4	next	Long Term Debt Maturities Repayments Of Principal In Rolling Year One Through Five LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearOneThroughFive	0	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive	1850000000	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1850000000	usd
CY2023Q4	next	Debt Instrument Covenant Repurchase Price Percentage DebtInstrumentCovenantRepurchasePricePercentage	1.01
CY2023	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	43268000	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	41390000	usd
CY2023	us-gaap	Interest Costs Incurred InterestCostsIncurred	84658000	usd
CY2023	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	34373000	usd
CY2023	us-gaap	Interest Expense InterestExpense	50285000	usd
CY2022Q4	next	Common Stock Warrant Liabilities CommonStockWarrantLiabilities	6790000	usd
CY2021Q4	next	Common Stock Warrant Liabilities CommonStockWarrantLiabilities	3963000	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1879000	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	5747000	usd
CY2023	next	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	0	usd
CY2022	next	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	3564000	usd
CY2023	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	0	usd
CY2022	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	644000	usd
CY2023Q4	next	Common Stock Warrant Liabilities CommonStockWarrantLiabilities	8669000	usd
CY2022Q4	next	Common Stock Warrant Liabilities CommonStockWarrantLiabilities	6790000	usd
CY2023Q2	next	Equity Offering Maximum Percentage Of Outstanding Common Stock EquityOfferingMaximumPercentageOfOutstandingCommonStock	0.175
CY2023Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	8000000	shares
CY2023Q2	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	40000000	usd
CY2023Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	22100000	shares
CY2023Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	110000000	usd
CY2023Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	14800000	shares
CY2023Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	69400000	usd
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6390000	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	49819000	shares
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	26553000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7472000	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	52500000	usd
CY2023	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y9M18D
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	0.06
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	0
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.02
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.01
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.01
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.13
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.19
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2023Q4	next	Deferred Tax Assets Operating Loss And Tax Credit Carryforwards DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwards	54839000	usd
CY2022Q4	next	Deferred Tax Assets Operating Loss And Tax Credit Carryforwards DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwards	36835000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	31782000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	749000	usd
CY2023Q4	next	Deferred Tax Assets Operating Lease Liabilities DeferredTaxAssetsOperatingLeaseLiabilities	2972000	usd
CY2022Q4	next	Deferred Tax Assets Operating Lease Liabilities DeferredTaxAssetsOperatingLeaseLiabilities	187000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	4996000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	3179000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	91465000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	36642000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	3124000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	4308000	usd
CY2023Q4	next	Deferred Tax Liabilities Operating Lease Right Of Use Assets DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets	2809000	usd
CY2022Q4	next	Deferred Tax Liabilities Operating Lease Right Of Use Assets DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets	4308000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	315000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	0	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	3124000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	4308000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	260700000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration	26100000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	23365000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2023	next	Accounts Payable Acquisition Of Property Plant And Equipment AccountsPayableAcquisitionOfPropertyPlantAndEquipment	238105000	usd
CY2022	next	Accounts Payable Acquisition Of Property Plant And Equipment AccountsPayableAcquisitionOfPropertyPlantAndEquipment	162000	usd
CY2023	next	Accrued Liabilities Acquisition Of Property Plant And Equipment AccruedLiabilitiesAcquisitionOfPropertyPlantAndEquipment	268821000	usd
CY2022	next	Accrued Liabilities Acquisition Of Property Plant And Equipment AccruedLiabilitiesAcquisitionOfPropertyPlantAndEquipment	12046000	usd
CY2023	next	Accrued Liabilities Acquisition Of Other Noncurrent Assets AccruedLiabilitiesAcquisitionOfOtherNoncurrentAssets	0	usd
CY2022	next	Accrued Liabilities Acquisition Of Other Noncurrent Assets AccruedLiabilitiesAcquisitionOfOtherNoncurrentAssets	279000	usd
CY2023	us-gaap	Dividends Preferred Stock Paidinkind DividendsPreferredStockPaidinkind	20431000	usd
CY2022	us-gaap	Dividends Preferred Stock Paidinkind DividendsPreferredStockPaidinkind	24207000	usd
CY2023	next	Accrued Liabilities Debt And Equity Issuance Costs AccruedLiabilitiesDebtAndEquityIssuanceCosts	764000	usd
CY2022	next	Accrued Liabilities Debt And Equity Issuance Costs AccruedLiabilitiesDebtAndEquityIssuanceCosts	0	usd
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001628280-24-010236-index-headers.html	Edgar Link	pending
0001628280-24-010236-index.html	Edgar Link	pending
0001628280-24-010236.txt	Edgar Link	pending
0001628280-24-010236-xbrl.zip	Edgar Link	pending
ex-1018.htm	Edgar Link	pending
ex-1045.htm	Edgar Link	pending
ex-1047.htm	Edgar Link	pending
ex-1050.htm	Edgar Link	pending
ex-1056.htm	Edgar Link	pending
ex-1057.htm	Edgar Link	pending
ex-1058.htm	Edgar Link	pending
ex-211.htm	Edgar Link	pending
ex-231.htm	Edgar Link	pending
ex-311.htm	Edgar Link	pending
ex-312.htm	Edgar Link	pending
ex-321.htm	Edgar Link	pending
ex-322.htm	Edgar Link	pending
ex-971.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_110.jpg	Edgar Link	pending
image_113.jpg	Edgar Link	pending
image_134.jpg	Edgar Link	pending
image_147.jpg	Edgar Link	pending
image_26.jpg	Edgar Link	pending
image_32.jpg	Edgar Link	pending
image_6.jpg	Edgar Link	pending
image_8.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
next-20231231.htm	Edgar Link	pending
next-20231231.xsd	Edgar Link	pending
next-20231231_g1.jpg	Edgar Link	pending
next-20231231_g2.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
next-20231231_def.xml	Edgar Link	unprocessable
next-20231231_lab.xml	Edgar Link	unprocessable
next-20231231_pre.xml	Edgar Link	unprocessable
next-20231231_htm.xml	Edgar Link	completed
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
next-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NEXT
NextDecade Corp. Stock $next

2024 Q1 Form 10-K Financial Statement

#000162828024010236 Filed on March 11, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NEXT NextDecade Corp. Stock $next

2024 Q1 Form 10-K Financial Statement

#000162828024010236 Filed on March 11, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NEXT
NextDecade Corp. Stock $next